V
RegisteredUS US · App #86739248 · Reg #5514115
Owned by
Bausch & Lomb IncorporatedApplication date
2015-08-27
Registration date
2018-07-10
Published date
2016-04-19
First use date
2017-11-09
Renewal date
—
Expiry date
—
Kind of mark
Trademark
Mark feature
Combined
NICE Classes
5Pharmaceuticals
Domestic Classes
Jurisdiction-specific classifications outside WIPO 1-45 (e.g. US old classes).
006018044046051052
Current owners
Applicants
- Bausch & Lomb Incorporated
Previous owners
- Bausch & Lomb Incorporated
- Bausch & Lomb Incorporated
Correspondence
- [Nancy L. Rowe] Bausch + Lomb
Activity Summary
Oppositions
0
P 0 · D 0
Assignments
20
Security: 7
Renewals
3
Prosecution events
83
Renewals & Maintenance
| Kind | Effective date | Status |
|---|---|---|
| Earliest Filing Date | 2027-07-10 | — |
| Latest Filing Date Without Additional Fee | 2028-07-10 | — |
| Latest Filing Date With Additional Fee | 2029-01-10 | — |
Assignments & Security Interests
| Date | Conveyance | Assignor → Assignee | Type |
|---|---|---|---|
| 2025-11-07 | RELEASE OF SECURITY INTEREST IN TRADEMARKS AT REEL/FRAME 6280/0211 | THE BANK OF NEW YORK MELLON → LABORATOIRE CHAUVIN S.A.S., ONPHARMA INC., SANTARUS, INC, SALIX PHARMACEUTICALS, LTD., ATON PHARMA, INC., SALIX PHARMACEUTICALS, INC., COMMONWEALTH LABORATORIES, LTD., BAUSCH & LOMB PHARMA HOLDINGS CORP., VALEANT PHARMACEUTICALS IRELAND LIMITED, MEDICIS PHARMACEUTICAL CORPORATION, TECHNOLAS PERFECT VISION GMBH, ECR PHARMACEUTICAL CO., INC., PRECISION DERMATOLOGY, INC., ALDEN OPTICAL LABORATORIES, INC., VALEANT PHARMACEUTICALS NORTH AMERICA LLC, VALEANT PHARMA POLAND SP. Z.O.O., INKINE PHARMACEUTICAL COMPANY, INC.., VALEANT CANADA LP, SOLTA MEDICAL, INC., DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L., ORAPHARMA, INC., VALEANT PHARMACEUTICALS INTERNATIONAL, UCYCLYD PHARMA, INC., BAUSCH & LOMB INCORPORATED, CORIA LABORATORIES, LLC, VALEANT PHARMACEUTICALS INTERNATIONAL, INC., OCEANSIDE PHARMACEUTICALS, INC., PRIVATE FORMULA CORP. | Release |
| 2025-08-13 | ASSIGNMENT OF SECURITY INTEREST IN TRADEMARKS PREVIOUSLY RECORDED AT REEL/FRAME (7717/0577) | CITIBANK, N.A., AS RESIGNING AGENT → JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT | Security |
| 2025-06-26 | TRADEMARK SECURITY AGREEMENT | BAUSCH & LOMB INCORPORATED, ALDEN OPTICAL LABORATORIES, INC., BAUSCH + LOMB IRELAND LIMITED → CITIBANK, N.A., AS NOTES COLLATERAL AGENT | Transfer |
| 2025-04-08 | RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY AT REEL/FRAME NO. 6280/0114 | BARCLAYS BANK PLC → BAUSCH HEALTH COMPANIES INC., ONPHARMA INC., SALIX PHARMACEUTICALS, LTD., ATON PHARMA, INC., SALIX PHARMACEUTICALS, INC., PRIVATE FORMULA CORPORATION, VALEANT PHARMACEUTICALS IRELAND LIMITED, EXZELL PHARMA INC., MEDICIS PHARMACEUTICAL CORPORATION, BAUSCH + LOMB IRELAND LIMITED, TECHNOLAS PERFECT VISION GMBH, VALEANT PHARMA POLAND SP. ZO.O., PRECISION DERMATOLOGY, INC., COMMONWEALTH LABORATORIES, LLC, VALEANT PHARMACEUTICALS IRELAND, BAUSCH HEALTH US, LLC, ALDEN OPTICAL LABORATORIES, INC., VALEANT PHARMACEUTICALS NORTH AMERICA, SOLTA MEDICAL, INC., VALEANT INTERNATIONAL (BARBADOS) SRL, BAUSCH HEALTH IRELAND LIMITED, ORAPHARMA, INC., OCEANSIDE PHARMACEUTICALS, INC., VALEANT PHARMACEUTICALS INTERNATIONAL, INKINE PHARMACEUTICAL COMPANY, INC., SANTARUS, INC., UCYCLYD PHARMA, INC., BAUSCH & LOMB INCORPORATED, VALEANT PHARMACEUTICALS LUXEMBOURG S.A.R.L., VALEANT PHARMACEUTICALS INTERNATIONAL, INC., VALEANT PHARMACEUTICALS NORTH AMERICA LLC, CORIA LABORATORIES, LTD. | Release |
| 2025-04-08 | RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY AT REEL/FRAME NO. 5836/0399 | BARCLAYS BANK PLC → BAUSCH + LOMB IRELAND LIMITED, VALEO PHARMA INC., AMBI ENTERPRISES, LLC, BAUSCH HEALTH COMPANIES INC., VALEANT PHARMA POLAND SP. Z O.O., VALEANT PHARMACEUTICALS LUXEMBOURG S.A.R.L., SPROUT PHARMACEUTICALS, INC., BAUSCH HEALTH IRELAND LIMITED, COMMONWEALTH LABORATORIES, LLC, VALEANT PHARMACEUTICALS INTERNATIONAL, INC., OBAGI COSMECEUTICALS LLC, VALEANT PHARMACEUTICALS NORTH AMERICA LLC, CORIA LABORATORIES, LTD., SOLTA MEDICAL, INC., BAUSCH & LOMB INCORPORATED | Release |
| 2023-09-29 | TRADEMARK SECURITY AGREEMENT | BAUSCH & LOMB INCORPORATED, ALDEN OPTICAL LABORATORIES, INC. → CITIBANK, N.A., AS NOTES COLLATERAL AGENT | Transfer |
| 2022-10-21 | RELEASE OF SECURITY INTEREST IN SPECIFIED TRADEMARKS (REEL/FRAME 5836/0399) | BARCLAYS BANK PLC → BAUSCH + LOMB IRELAND LIMITED, BAUSCH & LOMB INCORPORATED | Release |
| 2022-10-21 | RELEASE OF SECURITY INTEREST IN SPECIFIED TRADEMARKS (REEL/FRAME 6280/0114) | BARCLAYS BANK PLC → BAUSCH + LOMB IRELAND LIMITED, ALDEN OPTICAL LABORATORIES, INC., BAUSCH & LOMB INCORPORATED | Release |
| 2022-10-18 | OMNIBUS TRADEMARK SECURITY RELEASE AGREEMENT (REEL/FRAME 7320/0509) | THE BANK OF NEW YORK MELLON → ALDEN OPTICAL LABORATORIES, INC., BAUSCH & LOMB INCORPORATED | Release |
| 2022-10-18 | OMNIBUS TRADEMARK SECURITY RELEASE AGREEMENT (REEL/FRAME 6280/0211) | THE BANK OF NEW YORK MELLON → BAUSCH + LOMB IRELAND LIMITED, ALDEN OPTICAL LABORATORIES, INC., BAUSCH & LOMB INCORPORATED | Release |
| 2022-10-18 | OMNIBUS TRADEMARK SECURITY RELEASE AGREEMENT (REEL/FRAME 7630/0605) | THE BANK OF NEW YORK MELLON → ALDEN OPTICAL LABORATORIES, INC., BAUSCH & LOMB INCORPORATED | Release |
| 2022-10-18 | OMNIBUS TRADEMARK SECURITY RELEASE AGREEMENT (REEL/FRAME 6586/0877) | THE BANK OF NEW YORK MELLON → BAUSCH + LOMB IRELAND LIMITED, ALDEN OPTICAL LABORATORIES, INC., BAUSCH & LOMB INCORPORATED | Release |
| 2022-05-10 | TRADEMARK SECURITY AGREEMENT | BAUSCH & LOMB INCORPORATED, ALDEN OPTICAL LABORATORIES, INC. → CITIBANK, N.A. AS COLLATERAL AGENT | Transfer |
| 2022-02-10 | SECURITY AGREEMENT | ALDEN OPTICAL LABORATORIES, INC., BAUSCH & LOMB INCORPORATED, BAUSCH HEALTH US, LLC, MEDICIS PHARMACEUTICAL CORPORATION, OCEANSIDE PHARMACEUTICALS, INC., ORAPHARMA, INC., PRECISION DERMATOLOGY, INC., SALIX PHARMACEUTICALS, INC., SANTARUS, INC., SOLTA MEDICAL, INC., SALIX PHARMACEUTICALS, LTD., BAUSCH HEALTH AMERICAS, INC. → THE BANK OF NEW YORK MELLON | Transfer |
| 2021-06-08 | SECURITY INTEREST | ALDEN OPTICAL LABORATORIES, INC., BAUSCH & LOMB INCORPORATED, BAUSCH HEALTH US, LLC, MEDICIS PHARMACEUTICAL CORPORATION, OCEANSIDE PHARMACEUTICALS, INC., ORAPHARMA, INC., PRECISION DERMATOLOGY, INC., SALIX PHARMACEUTICALS, INC., SANTARUS, INC., SOLTA MEDICAL, INC., SALIX PHARMACEUTICALS, LTD., BAUSCH HEALTH AMERICAS, INC. → THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT | Security |
| 2019-03-08 | CORRECTIVE ASSIGNMENT TO CORRECT THE REGISTRATION NUMBERS PREVIOUSLY RECORDED AT REEL: 006586 FRAME: 0877. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST. | ALDEN OPTICAL LABORATORIES, INC., BAUSCH & LOMB INCORPORATED, BAUSCH HEALTH AMERICAS, INC., MEDICIS PHARMACEUTICAL CORPORATION, OCEANSIDE PHARMACEUTICALS, INC., ORAPHARMA, INC., PRECISION DERMATOLOGY, INC., SALIX PHARMACEUTICALS, LTD., SALIX PHARMACEUTICALS, INC., PRIVATE FORMULA CORP., BAUSCH HEALTH US, LLC, SANTARUS, INC., SOLTA MEDICAL, INC. → THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT | Security |
| 2019-03-08 | SECURITY INTEREST | ALDEN OPTICAL LABORATORIES, INC., BAUSCH & LOMB INCORPORATED, BAUSCH HEALTH AMERICAS, INC., BAUSCH HEALTH US, LLC, MEDICIS PHARMACEUTICAL CORPORATION, OCEANSIDE PHARMACEUTICALS, INC., ORAPHARMA, INC., PRECISION DERMATOLOGY, INC., SALIX PHARMACEUTICALS, LTD., SALIX PHARMACEUTICALS, INC., SANTARUS, INC., SOLTA MEDICAL, INC., PRIVATE FORMULA CORP. → THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT | Security |
| 2018-02-13 | SECURITY INTEREST | ALDEN OPTICAL LABORATORIES, INC., ATON PHARMA, INC., BAUSCH & LOMB INCORPORATED, BAUSCH & LOMB PHARMA HOLDINGS CORP., COMMONWEALTH LABORATORIES, LLC, CORIA LABORATORIES, LTD., DOW PHARMACEUTICAL SCIENCES, INC., ECR PHARMACEUTICALS CO., INC., INKINE PHARMACEUTICAL COMPANY, INC., LABORATOIRE CHAUVIN S.A.S., MEDICIS PHARMACEUTICAL CORPORATION, OCEANSIDE PHARMACEUTICALS, INC., ONPHARMA INC., ORAPHARMA, INC., PRECISION DERMATOLOGY, INC., PRIVATE FORMULA CORP., SALIX PHARMACEUTICALS, LTD., SALIX PHARMACEUTICALS, INC., SANTARUS, INC., SOLTA MEDICAL, INC., TECHNOLAS PERFECT VISION GMBH, UCYCLYD PHARMA, INC., VALEANT CANADA LP, VALEANT PHARMACEUTICALS INTERNATIONAL, VALEANT PHARMACEUTICALS INTERNATIONAL, INC., VALEANT PHARMACEUTICALS NORTH AMERICA LLC, VALEANT PHARMA POLAND SP. Z O.O., VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L., VALEANT PHARMACEUTICALS IRELAND LIMITED → THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT | Security |
| 2018-02-13 | SECURITY INTEREST | ALDEN OPTICAL LABORATORIES, INC., ATON PHARMA, INC., BAUSCH & LOMB INCORPORATED, BAUSCH & LOMB PHARMA HOLDINGS CORP., COMMONWEALTH LABORATORIES, LLC, CORIA LABORATORIES, LTD., DOW PHARMACEUTICAL SCIENCES, INC., ECR PHARMACEUTICALS CO., INC., INKINE PHARMACEUTICAL COMPANY, INC., LABORATOIRE CHAUVIN S.A.S., MEDICIS PHARMACEUTICAL CORPORATION, OCEANSIDE PHARMACEUTICALS, INC., ONPHARMA INC., ORAPHARMA, INC., PRECISION DERMATOLOGY, INC., PRIVATE FORMULA CORP., SALIX PHARMACEUTICALS, LTD., SALIX PHARMACEUTICALS, INC., SANTARUS, INC., SOLTA MEDICAL, INC., TECHNOLAS PERFECT VISION GMBH, UCYCLYD PHARMA, INC., VALEANT CANADA LP, VALEANT PHARMACEUTICALS INTERNATIONAL, VALEANT PHARMACEUTICALS INTERNATIONAL, INC., VALEANT PHARMACEUTICALS NORTH AMERICA LLC, VALEANT PHARMA POLAND SP. Z O.O., VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L., VALEANT PHARMACEUTICALS IRELAND LIMITED → BARCLAY'S BANK PLC, AS COLLATERAL AGENT | Security |
| 2016-07-18 | SECURITY INTEREST | BAUSCH & LOMB INCORPORATED, COMMONWEALTH LABORATORIES, LLC, CORIA LABORATORIES, LTD., DOW PHARMACEUTICAL SCIENCES, INC., OMP, INC., ORAPHARMA, INC., PRECISION DERMATOLOGY, INC., SOLTA MEDICAL, INC., SPROUT PHARMACEUTICALS, INC., TECHNOLAS PERFECT VISION GMBH, VALEANT CANADA LP, BY ITS GENERAL PARTNER VALEANT CANADA GP LIMITED, VALEANT HOLDINGS IRELAND, VALEANT PHARMACEUTICALS INTERNATIONAL, INC., VALEANT PHARMACEUTICALS LUXEMBOURG S.A.R.L., VALEANT PHARMACEUTICALS NORTH AMERICA LLC, VALEANT PHARMACEUTICALS IRELAND → BARCLAYS BANK PLC | Security |
Prosecution History
83 events| Date | Event |
|---|---|
| 2026-02-18 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2026-02-18 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2026-02-18 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2026-02-18 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2026-02-18 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2026-02-18 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2026-02-18 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2026-02-18 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2026-02-11 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2025-09-10 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2025-07-25 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2025-04-16 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2024-12-12 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
| 2024-12-12 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| 2024-12-12 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 2024-07-09 | TEAS SECTION 8 & 15 RECEIVED |
| 2023-10-11 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2023-07-10 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 2022-12-28 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2022-12-21 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2022-12-14 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2022-10-10 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 2022-10-10 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 2022-10-10 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 2022-10-10 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 2022-10-10 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 2022-06-23 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2022-05-25 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2022-03-09 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2021-10-16 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 2021-10-16 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 2021-10-16 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 2020-11-25 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 2020-09-10 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 2020-09-10 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 2020-09-10 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 2020-09-10 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 2020-09-10 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 2020-05-03 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 2020-05-03 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 2020-05-03 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 2018-07-10 | REGISTERED-PRINCIPAL REGISTER |
| 2018-06-02 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 2018-06-01 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 2018-05-08 | STATEMENT OF USE PROCESSING COMPLETE |
| 2018-05-03 | USE AMENDMENT FILED |
| 2018-05-03 | TEAS STATEMENT OF USE RECEIVED |
| 2017-12-15 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2017-12-13 | SOU EXTENSION 3 GRANTED |
| 2017-12-13 | SOU EXTENSION 3 FILED |
Showing first 50 of 83 events